Potential of stem cell therapy in intracerebral hemorrhage
Journal
Molecular Biology Reports
Journal Volume
47
Journal Issue
6
Pages
4671-4680
Date Issued
2020
Author(s)
Hsu, Yi-Hua
Wu, Meng-Shiue
Tsai, Hsin-Han
Su, Chia-Yi
Abstract
Spontaneous intracerebral hemorrhage (ICH) is a common disease associated with high mortality and morbidity. The treatment of patients with ICH includes medical and surgical interventions. New areas of surgical intervention have been focused on the evacuation of hematoma through minimally invasive neurosurgery. In contrast, there have been no significant advances in the development of medical interventions for functional recovery after ICH. Stem cells exert multiple therapeutic functions and have emerged as a promising treatment strategy. Herein, we summarized the pathophysiology of ICH and its treatment targets, and we introduced the therapeutic mechanisms of stem cells (e.g. neutrotrophy and neuroregeneration). Moreover, we reviewed and summarized the experimental designs of the preclinical studies, including the types of cells and the timing and routes of stem cell administration. We further listed and reviewed the completed/published and ongoing clinical trials supporting the safety and efficacy of stem cell therapy in ICH. The limitations of translating preclinical studies into clinical trials and the objectives of future studies were discussed. In conclusion, current literatures showed that stem cell therapy is a promising treatment in ICH and further translation research on judiciously selected group of patients is warranted before it can be extensively applied in clinical practice. ? 2020, Springer Nature B.V.
SDGs
Other Subjects
adipose derived stem cell; bone marrow derived mesenchymal stem cell; brain hemorrhage; clinical effectiveness; human; induced pluripotent stem cell; intracranial pressure; mesenchymal stem cell; neural stem cell; nonhuman; pathophysiology; prognosis; Review; stem cell transplantation; treatment indication; treatment outcome; umbilical cord; umbilical cord derived mesenchymal stem cell; biological therapy; brain hemorrhage; hematoma; metabolism; procedures; stem cell; stem cell transplantation; Cell- and Tissue-Based Therapy; Cerebral Hemorrhage; Hematoma; Humans; Stem Cell Transplantation; Stem Cells
Publisher
Springer
Type
review